CollPlant Biotechnologies Ltd. (ADR)
General ticker "CLGN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $32.0M (TTM average)
CollPlant Biotechnologies Ltd. (ADR) does not follow the US Stock Market performance with the rate: -6.2%.
Estimated limits based on current volatility of 3.2%: low 1.99$, high 2.12$
Factors to consider:
- Total employees count: 39 as of 2017
- Current price 11.9% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.38$, 5.57$]
- 2025-12-31 to 2026-12-31 estimated range: [2.31$, 5.37$]
Financial Metrics affecting the CLGN estimates:
- Positive: with PPE of -2.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -34.49 <= 0.33
- Positive: Shareholder equity ratio, % of 71.97 > 63.39
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Negative: Industry earnings per price (median), % of -16.34 <= 0
Short-term CLGN quotes
Long-term CLGN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.30MM | $10.96MM | $0.52MM |
| Operating Expenses | $17.40MM | $18.47MM | $17.77MM |
| Operating Income | $-17.10MM | $-7.51MM | $-17.25MM |
| Non-Operating Income | $0.17MM | $0.49MM | $0.64MM |
| Interest Expense | $0.03MM | $0.01MM | $0.02MM |
| R&D Expense | $10.26MM | $10.48MM | $10.52MM |
| Income(Loss) | $-16.93MM | $-7.02MM | $-16.61MM |
| Profit(Loss)* | $-16.75MM | $-7.02MM | $-16.61MM |
| Stockholders Equity | $32.28MM | $28.34MM | $13.46MM |
| Inventory | $1.43MM | $0.71MM | $0.44MM |
| Assets | $37.77MM | $34.13MM | $18.71MM |
| Operating Cash Flow | $-13.70MM | $-2.76MM | $-14.09MM |
| Capital expenditure | $1.32MM | $0.95MM | $0.48MM |
| Investing Cash Flow | $28.92MM | $-1.16MM | $-0.54MM |
| Financing Cash Flow | $1.87MM | $1.11MM | $0.01MM |
| Earnings Per Share** | $-1.52 | $-0.62 | $-1.45 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.